Tag: DiaMedica Therapeutics
December 31, 2018
4 Life Science IPOs in December
December brought four life science IPOs on the NASDAQ, giving investors new opportunities to enter the market. December 7, 2018
DIAMEDICA ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING AND NASDAQ LISTING
DiaMedica Therapeutics (NASDAQ:DMAC) (TSXV:DMA), a clinical stage biopharmaceutical company, announced today the pricing of its initial public offering in the... September 27, 2018
DiaMedica Therapeutics and Ahon Pharma Announces Signing of License Agreement for DM199 in China for Acute Ischemic Stroke
Ahon Pharmaceutical a subsidiary of Shanghai Fosun Pharmaceutical (HKG:02196,SHA:600196) and DiaMedica Therapeutics (TSXV:DMA,OTCQB:DMCAF) entered into a license and collaboration agreement,... May 1, 2017
DiaMedica Granted US Patent for DM199
DiaMedica Therapeutics received a patent for DM199 from the US Patent and Trademark Office.
April 13, 2017